Cargando…
CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis
Papillary thyroid cancer (PTHCA) accounts for ~85% cases of thyroid cancer and exhibits high incidence. Targeted therapy is an effective method to combat this disease; however, novel therapeutic targets are required. Centromere protein F (CENPF), a member of centromere proteins and a transient kinet...
Autores principales: | Han, Yong, Xu, Shujian, Cheng, Kai, Diao, Caimei, Liu, Song, Zou, Weiwei, Bi, Yueyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918471/ https://www.ncbi.nlm.nih.gov/pubmed/33680123 http://dx.doi.org/10.3892/etm.2021.9832 |
Ejemplares similares
-
CENPF promotes the proliferation of renal cell carcinoma in vitro
por: Zhang, Ji, et al.
Publicado: (2023) -
Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2021) -
Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021) -
[Retracted] Upregulation of CENPF is linked to aggressive features of osteosarcoma
por: Zou, Ping-An, et al.
Publicado: (2023) -
FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)